Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients

Elimor Brand-Schieber,1 Sagar Munjal,1 Rajesh Kumar,1 Anthony D Andre,2 Will Valladao,2 Margarita Ramirez2 1Dr. Reddy’s Laboratories Inc., Princeton, NJ, 2Interface Analysis Associates, Saratoga, CA, USA Background: Migraine pain relief is reported by more than 50% of patients who receive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brand-Schieber E, Munjal S, Kumar R, Andre AD, Valladao W, Ramirez M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/a2eb8fb1d91640138c1c1af8a4b6abbc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!